Topical imiquimod immunotherapy in the management of lentigo maligna.
about
Developments in Intralesional Therapy for Metastatic MelanomaA systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Use of imiquimod for residual acral melanomaImiquimod in the treatment of lentigo maligna.Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna.Diagnosis and management of lentigo maligna: a reviewA systematic review of non-surgical treatments for lentigo maligna.The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.Use of topical immunomodulators in organ transplant recipients.Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.Intralesional therapy for metastatic melanoma.The importance of surgical margins in melanoma.Toll-like receptors and cutaneous melanoma.Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients.
P2860
Q28069615-C4718DE7-E823-44BC-B530-C11F0575134FQ30240021-14518B77-42C3-4A30-BE39-310D0CDB91AFQ33293591-C295A39B-DE0A-436F-98C5-D1561D4E8819Q33509292-C168F192-5373-41F5-AE9D-6FDC398CAA49Q34130648-68974405-B7AE-4F8D-A32D-3C2775B669EAQ34565175-901AB264-8413-4841-8552-68E86EEC4E2AQ35181048-A7FA76C4-AD6A-4431-A03E-FC4746EFB32EQ35678220-78681F46-2771-4C17-BB98-22F1719F0B0DQ35753267-0CE1A14A-E084-41C4-B39A-466A38F3FCC2Q36102807-1657F42D-7D6F-4D1E-970C-182D027ECAF8Q36103147-EB4DE8C2-132C-4AAC-8DC6-2EB9B70F4772Q36372198-5BBCC859-BAC9-4D1A-88D1-2E320A0A3E83Q37763742-E343BA2E-84B4-4BAE-BF3C-4AAE8D0DD782Q38088212-063127DC-0407-4C9F-B7CE-6BED7FFF678FQ38266193-FE4373F6-DB92-41A6-9F96-7B3BF8F542AAQ38667983-D2D8B1AE-B156-4E7A-BDEB-73E28CD172BBQ39023996-2FFFFA89-B5F9-4B4D-A476-60B8314360CFQ42474649-E8692F7C-3C7B-4E96-8FCD-F5CF83337F29
P2860
Topical imiquimod immunotherapy in the management of lentigo maligna.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Topical imiquimod immunotherapy in the management of lentigo maligna.
@en
Topical imiquimod immunotherapy in the management of lentigo maligna.
@nl
type
label
Topical imiquimod immunotherapy in the management of lentigo maligna.
@en
Topical imiquimod immunotherapy in the management of lentigo maligna.
@nl
prefLabel
Topical imiquimod immunotherapy in the management of lentigo maligna.
@en
Topical imiquimod immunotherapy in the management of lentigo maligna.
@nl
P2093
P2860
P1476
Topical imiquimod immunotherapy in the management of lentigo maligna.
@en
P2093
A M Powell
R J Barlow
R Russell-Jones
P2860
P356
10.1111/J.1365-2230.2004.01452.X
P577
2004-01-01T00:00:00Z